These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 17632268)
1. Amyloid-beta and synaptic activity in mice and men. Ihara M; Kalaria RN Neuroreport; 2007 Aug; 18(12):1205-6. PubMed ID: 17632268 [No Abstract] [Full Text] [Related]
2. Impairments of hippocampal synaptic plasticity induced by aggregated beta-amyloid (25-35) are dependent on stimulation-protocol and genetic background. Gengler S; Gault VA; Harriott P; Hölscher C Exp Brain Res; 2007 Jun; 179(4):621-30. PubMed ID: 17171334 [TBL] [Abstract][Full Text] [Related]
3. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42). Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377 [TBL] [Abstract][Full Text] [Related]
5. Genetic ablation of luteinizing hormone receptor improves the amyloid pathology in a mouse model of Alzheimer disease. Lin J; Li X; Yuan F; Lin L; Cook CL; Rao ChV; Lei Z J Neuropathol Exp Neurol; 2010 Mar; 69(3):253-61. PubMed ID: 20142765 [TBL] [Abstract][Full Text] [Related]
6. Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Wang J; Tanila H; Puoliväli J; Kadish I; van Groen T Neurobiol Dis; 2003 Dec; 14(3):318-27. PubMed ID: 14678749 [TBL] [Abstract][Full Text] [Related]
7. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains. Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307 [TBL] [Abstract][Full Text] [Related]
8. Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice. Gordon MN; King DL; Diamond DM; Jantzen PT; Boyett KV; Hope CE; Hatcher JM; DiCarlo G; Gottschall WP; Morgan D; Arendash GW Neurobiol Aging; 2001; 22(3):377-85. PubMed ID: 11378242 [TBL] [Abstract][Full Text] [Related]
9. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. Dewachter I; Reversé D; Caluwaerts N; Ris L; Kuipéri C; Van den Haute C; Spittaels K; Umans L; Serneels L; Thiry E; Moechars D; Mercken M; Godaux E; Van Leuven F J Neurosci; 2002 May; 22(9):3445-53. PubMed ID: 11978821 [TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor (VEGF) affects processing of amyloid precursor protein and beta-amyloidogenesis in brain slice cultures derived from transgenic Tg2576 mouse brain. Bürger S; Noack M; Kirazov LP; Kirazov EP; Naydenov CL; Kouznetsova E; Yafai Y; Schliebs R Int J Dev Neurosci; 2009 Oct; 27(6):517-23. PubMed ID: 19589380 [TBL] [Abstract][Full Text] [Related]
11. Prion infection of mice transgenic for human APPSwe: increased accumulation of cortical formic acid extractable Abeta(1-42) and rapid scrapie disease development. Baier M; Apelt J; Riemer C; Gültner S; Schwarz A; Bamme T; Burwinkel M; Schliebs R Int J Dev Neurosci; 2008 Nov; 26(7):821-4. PubMed ID: 18662767 [TBL] [Abstract][Full Text] [Related]
12. Ablating ErbB4 in PV neurons attenuates synaptic and cognitive deficits in an animal model of Alzheimer's disease. Zhang H; Zhang L; Zhou D; He X; Wang D; Pan H; Zhang X; Mei Y; Qian Q; Zheng T; Jones FE; Sun B Neurobiol Dis; 2017 Oct; 106():171-180. PubMed ID: 28684271 [TBL] [Abstract][Full Text] [Related]
13. [The role of Alzheimer amyloid plaques in the mechanisms of neuron synaptic plasticity disturbance]. Berezov TT; Kudinova NV; Kudinov AP Vestn Ross Akad Med Nauk; 2005; (10):3-7. PubMed ID: 16320698 [TBL] [Abstract][Full Text] [Related]
14. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835 [TBL] [Abstract][Full Text] [Related]
15. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice. Kimura R; Devi L; Ohno M J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133 [TBL] [Abstract][Full Text] [Related]
16. Selective nicotinic receptor consequences in APP(SWE) transgenic mice. Bednar I; Paterson D; Marutle A; Pham TM; Svedberg M; Hellström-Lindahl E; Mousavi M; Court J; Morris C; Perry E; Mohammed A; Zhang X; Nordberg A Mol Cell Neurosci; 2002 Jun; 20(2):354-65. PubMed ID: 12093166 [TBL] [Abstract][Full Text] [Related]
17. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease. Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966 [TBL] [Abstract][Full Text] [Related]
18. Transgenic animals in Alzheimer's disease research. Sturchler-Pierrat C; Sommer B Rev Neurosci; 1999; 10(1):15-24. PubMed ID: 10356989 [TBL] [Abstract][Full Text] [Related]
19. Amyloid-beta: a (life) preserver for the brain. Obrenovich ME; Joseph JA; Atwood CS; Perry G; Smith MA Neurobiol Aging; 2002; 23(6):1097-9. PubMed ID: 12470809 [No Abstract] [Full Text] [Related]
20. Probiotic treatment improves the impaired spatial cognitive performance and restores synaptic plasticity in an animal model of Alzheimer's disease. Rezaei Asl Z; Sepehri G; Salami M Behav Brain Res; 2019 Dec; 376():112183. PubMed ID: 31472194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]